Hikma Pharmaceuticals.
71 announcements.
71 announcements.
| Time | Date | Ticker | Company | Announcement |
|---|---|---|---|---|
| 11:45 | 01-10-2025 | HIK | Hikma Pharmaceuticals | Block listing Interim Review |
| 13:52 | 23-09-2025 | HIK | Hikma Pharmaceuticals | Director/PDMR Shareholding |
| 09:16 | 17-09-2025 | HIK | Hikma Pharmaceuticals | Director/PDMR Shareholding |
| 12:02 | 22-08-2025 | HIK | Hikma Pharmaceuticals | Director/PDMR Shareholding |
| 13:51 | 13-08-2025 | HIK | Hikma Pharmaceuticals | Director/PDMR Shareholding |
| 12:59 | 08-08-2025 | HIK | Hikma Pharmaceuticals | Director/PDMR Shareholding |
| 07:00 | 07-08-2025 | HIK | Hikma Pharmaceuticals | Half-year Report |
| 09:00 | 09-07-2025 | HIK | Hikma Pharmaceuticals | Notice of Results |
| 09:16 | 07-07-2025 | HIK | Hikma Pharmaceuticals | Publication of Offering Circular |
| 15:33 | 09-06-2025 | HIK | Hikma Pharmaceuticals | Director/PDMR Shareholding |
| 14:05 | 05-06-2025 | HIK | Hikma Pharmaceuticals | Director/PDMR Shareholding |
| 13:02 | 03-06-2025 | HIK | Hikma Pharmaceuticals | Director/PDMR Shareholding |
| 07:00 | 29-05-2025 | HIK | Hikma Pharmaceuticals | Fitch upgrades Hikma to ‘BBB’ |
| 14:49 | 20-05-2025 | HIK | Hikma Pharmaceuticals | Director/PDMR Shareholding |
| 12:00 | 15-05-2025 | HIK | Hikma Pharmaceuticals | Medium-term Group guidance ahead of US site visit |
| 16:35 | 08-05-2025 | HIK | Hikma Pharmaceuticals | Director/PDMR Shareholding |
| 10:48 | 08-05-2025 | HIK | Hikma Pharmaceuticals | S&P upgrades Hikma to ‘BBB’ |
| 08:21 | 08-05-2025 | HIK | Hikma Pharmaceuticals | Settlement agreement for Xyrem® US lawsuits |
| 13:21 | 30-04-2025 | HIK | Hikma Pharmaceuticals | Director/PDMR Shareholding |
| 15:55 | 24-04-2025 | HIK | Hikma Pharmaceuticals | Result of AGM |
| 07:00 | 24-04-2025 | HIK | Hikma Pharmaceuticals | Trading Statement |
| 14:36 | 10-04-2025 | HIK | Hikma Pharmaceuticals | Director/PDMR Shareholding |
| 13:47 | 08-04-2025 | HIK | Hikma Pharmaceuticals | Director/PDMR Shareholding |
| 09:30 | 01-04-2025 | HIK | Hikma Pharmaceuticals | Block listing Interim Review |
| 10:10 | 19-03-2025 | HIK | Hikma Pharmaceuticals | Annual Financial Report and Notice of AGM |
| 11:16 | 04-03-2025 | HIK | Hikma Pharmaceuticals | Director/PDMR Shareholding |
| 07:00 | 26-02-2025 | HIK | Hikma Pharmaceuticals | Final Results |
| 08:09 | 10-02-2025 | HIK | Hikma Pharmaceuticals | Notice of Results |
| 09:46 | 23-12-2024 | HIK | Hikma Pharmaceuticals | Director/PDMR Shareholding |
| 15:30 | 07-11-2024 | HIK | Hikma Pharmaceuticals | Outcome of Audit Tender Process |
| 07:00 | 07-11-2024 | HIK | Hikma Pharmaceuticals | Trading Statement |
| 07:00 | 24-10-2024 | HIK | Hikma Pharmaceuticals | 2024 Annual General Meeting Update Statement |
| 09:45 | 01-10-2024 | HIK | Hikma Pharmaceuticals | Block listing Interim Review |
| 10:09 | 24-09-2024 | HIK | Hikma Pharmaceuticals | Director/PDMR Shareholding |
| 07:00 | 10-09-2024 | HIK | Hikma Pharmaceuticals | Hikma completes Xellia acquisition |
| 09:39 | 13-08-2024 | HIK | Hikma Pharmaceuticals | Director/PDMR Shareholding |
| 07:00 | 08-08-2024 | HIK | Hikma Pharmaceuticals | Half-year Report |
| 07:00 | 15-07-2024 | HIK | Hikma Pharmaceuticals | Notice of Results |
| 14:47 | 01-07-2024 | HIK | Hikma Pharmaceuticals | Total Voting Rights |
| 13:47 | 27-06-2024 | HIK | Hikma Pharmaceuticals | Director Declaration |
| 07:00 | 17-06-2024 | HIK | Hikma Pharmaceuticals | Hikma acquires Xellia’s assets |
| 14:53 | 05-06-2024 | HIK | Hikma Pharmaceuticals | Director/PDMR Shareholding |
| 09:49 | 09-05-2024 | HIK | Hikma Pharmaceuticals | Director/PDMR Shareholding |
| 14:28 | 25-04-2024 | HIK | Hikma Pharmaceuticals | Result of AGM |
| 07:00 | 25-04-2024 | HIK | Hikma Pharmaceuticals | Trading Statement |
| 10:58 | 11-04-2024 | HIK | Hikma Pharmaceuticals | Director/PDMR Shareholding |
| 09:50 | 02-04-2024 | HIK | Hikma Pharmaceuticals | Block listing Interim Review |
| 09:21 | 22-03-2024 | HIK | Hikma Pharmaceuticals | Annual Financial Report and Notice of AGM |
| 09:42 | 13-03-2024 | HIK | Hikma Pharmaceuticals | Director/PDMR Shareholding |
| 13:52 | 07-03-2024 | HIK | Hikma Pharmaceuticals | Director/PDMR Shareholding |
| 10:17 | 01-03-2024 | HIK | Hikma Pharmaceuticals | Total Voting Rights |
| 07:00 | 22-02-2024 | HIK | Hikma Pharmaceuticals | Final Results |
| 08:46 | 05-02-2024 | HIK | Hikma Pharmaceuticals | Notice of Results |
| 12:08 | 01-02-2024 | HIK | Hikma Pharmaceuticals | Total Voting Rights |
| 15:24 | 02-01-2024 | HIK | Hikma Pharmaceuticals | Total Voting Rights |
| 07:00 | 29-12-2023 | HIK | Hikma Pharmaceuticals | Company Secretary Change |
| 07:00 | 01-12-2023 | HIK | Hikma Pharmaceuticals | Total Voting Rights |
| 07:00 | 02-11-2023 | HIK | Hikma Pharmaceuticals | Trading Statement |
| 10:13 | 02-10-2023 | HIK | Hikma Pharmaceuticals | Block listing Interim Review |
| 10:04 | 02-10-2023 | HIK | Hikma Pharmaceuticals | Total Voting Rights |
| 07:00 | 01-09-2023 | HIK | Hikma Pharmaceuticals | Total Voting Rights |
| 16:14 | 31-08-2023 | HIK | Hikma Pharmaceuticals | Director/PDMR Shareholding |
| 14:00 | 11-08-2023 | HIK | Hikma Pharmaceuticals | Director/PDMR Shareholding |
| 16:53 | 10-08-2023 | HIK | Hikma Pharmaceuticals | Director/PDMR Shareholding |
| 07:00 | 03-08-2023 | HIK | Hikma Pharmaceuticals | Half-year Report |
| 09:11 | 17-07-2023 | HIK | Hikma Pharmaceuticals | Notice of Results |
| 10:03 | 14-06-2023 | HIK | Hikma Pharmaceuticals | Holding(s) in Company |
| 10:25 | 08-06-2023 | HIK | Hikma Pharmaceuticals | Director/PDMR Shareholding |
| 15:20 | 31-05-2023 | HIK | Hikma Pharmaceuticals | Director/PDMR Shareholding |
| 16:14 | 23-05-2023 | HIK | Hikma Pharmaceuticals | Holding(s) in Company |
| 09:56 | 17-05-2023 | HIK | Hikma Pharmaceuticals | Director/PDMR Shareholding |